PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
Drug company executives on Tuesday touted their industry’s work to keep and make Americans healthy during a Washington event.
A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
As Republicans gear up to pass the first major tax bill since the 2017 Tax Cuts and Jobs Act, Citibank hired Ernst & Young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results